Jakarta - Delayed Quote IDR

PT Tempo Scan Pacific Tbk (TSPC.JK)

Compare
2,460.00
+10.00
+(0.41%)
At close: March 27 at 4:07:38 PM GMT+7
Loading Chart for TSPC.JK
  • Previous Close 2,450.00
  • Open 2,450.00
  • Bid 2,450.00 x --
  • Ask 2,460.00 x --
  • Day's Range 2,410.00 - 2,480.00
  • 52 Week Range 1,870.00 - 2,900.00
  • Volume 1,217,000
  • Avg. Volume 1,155,389
  • Market Cap (intraday) 11.094T
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) 7.66
  • EPS (TTM) 321.03
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield 100.00 (4.07%)
  • Ex-Dividend Date Dec 3, 2024
  • 1y Target Est --

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products. The company sells its products under the Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Vidoran, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, MY BABY, MY BABY Kids, Pure Baby, S.O.S, Total Care, and ULTIMA II brands. It also engages in the construction and rental of buildings; provision of warehousing, freight forwarding, advertising and promotion, research and development, and information technology and communication network systems services; and procurement, distribution, and marketing activities. PT Tempo Scan Pacific Tbk was formerly known as PT Scanchemie. The company was founded in 1970 and is headquartered in Jakarta, Indonesia. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi.

www.temposcangroup.com

4,480

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TSPC.JK

View More

Performance Overview: TSPC.JK

Trailing total returns as of 3/27/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

TSPC.JK
1.60%
IDX COMPOSITE (^JKSE)
8.04%

1-Year Return

TSPC.JK
29.08%
IDX COMPOSITE (^JKSE)
10.94%

3-Year Return

TSPC.JK
102.84%
IDX COMPOSITE (^JKSE)
7.02%

5-Year Return

TSPC.JK
237.52%
IDX COMPOSITE (^JKSE)
43.23%

Compare To: TSPC.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TSPC.JK

View More

Valuation Measures

Annual
As of 3/27/2025
  • Market Cap

    11.09T

  • Enterprise Value

    7.37T

  • Trailing P/E

    7.66

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.81

  • Price/Book (mrq)

    1.28

  • Enterprise Value/Revenue

    0.54

  • Enterprise Value/EBITDA

    3.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.60%

  • Return on Assets (ttm)

    9.50%

  • Return on Equity (ttm)

    17.99%

  • Revenue (ttm)

    13.65T

  • Net Income Avi to Common (ttm)

    1.45T

  • Diluted EPS (ttm)

    321.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.58T

  • Total Debt/Equity (mrq)

    9.39%

  • Levered Free Cash Flow (ttm)

    921.12B

Research Analysis: TSPC.JK

View More

Company Insights: TSPC.JK

Research Reports: TSPC.JK

View More

People Also Watch